Nuclear matrix localization and SUMO-1 modification of adenovirus type 5 E1b 55K protein are controlled by E4 Orf6 protein

被引:44
作者
Lethbridge, KJ [1 ]
Scott, GE [1 ]
Leppard, KN [1 ]
机构
[1] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England
基金
英国生物技术与生命科学研究理事会;
关键词
D O I
10.1099/vir.0.18820-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human adenovirus serotype 5 encodes three proteins, E1b 55K, E4 Orf3 and E4 Orf6, which interact with each other and with components of the nucleus to regulate mRNA processing and export, viral DNA replication and p53-dependent apoptosis. Previous studies have shown that, during wild-type infection, 55K associates initially with structures termed ND10, which are sites of localization of the promyelocytic leukaemia protein, and then moves, dependent upon its interaction with Orf6, to the establishing virus replication centres. Absence of either Orf3 or Orf6 affects the localization of 55K and so may affect its function. In this study, the influence of Orf3 and Orf6 expression on the association of 55K with the insoluble matrix fraction of the nucleus and with ND10 particularly was examined. Overexpression of Orf6 was sufficient to block the association of 55K with this fraction, irrespective of the presence of Orf3. This effect depended upon the two proteins being able to interact. However, the association of 55K with ND10, which persists throughout infection in the absence of Orf6, required Orf3 to be present, thus distinguishing two subsets of matrix-associated 55K. A modified form of 55K, formation of which was blocked by mutating the known site of SUMO-1 attachment, was more abundant in the absence of Orf6 but unaffected by the absence of Orf3. Thus, this modification is favoured when 55K remains associated with the matrix but does not correlate with its stable association with ND10, many components of which are modified by SUMO-1.
引用
收藏
页码:259 / 268
页数:10
相关论文
共 45 条
[1]   Adenovirus E4 open reading frame 4 protein autoregulates E4 transcription by inhibiting E1A transactivation of the E4 promoter [J].
Bondesson, M ;
Ohman, K ;
Mannervik, M ;
Fan, S ;
Akusjarvi, G .
JOURNAL OF VIROLOGY, 1996, 70 (06) :3844-3851
[2]   TARGETING OF ADENOVIRUS E1A AND E4-ORF3 PROTEINS TO NUCLEAR MATRIX-ASSOCIATED PML BODIES [J].
CARVALHO, T ;
SEELER, JS ;
OHMAN, K ;
JORDAN, P ;
PETTERSSON, U ;
AKUSJARVI, G ;
CARMOFONSECA, M ;
DEJEAN, A .
JOURNAL OF CELL BIOLOGY, 1995, 131 (01) :45-56
[3]   Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein [J].
Chelbi-Alix, MK ;
Quignon, F ;
Pelicano, L ;
Koken, MHM ;
De Thé, H .
JOURNAL OF VIROLOGY, 1998, 72 (02) :1043-1051
[4]   ANALYSIS OF ADENOVIRUS EARLY REGION 4 ENCODED POLYPEPTIDES SYNTHESIZED IN PRODUCTIVELY INFECTED-CELLS [J].
CUTT, JR ;
SHENK, T ;
HEARING, P .
JOURNAL OF VIROLOGY, 1987, 61 (02) :543-552
[5]   EXPRESSION OF ADENOVIRUS TYPE-5 E4 ORF2 PROTEIN DURING LYTIC INFECTION [J].
DIX, I ;
LEPPARD, KN .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :1051-1055
[6]   REGULATED SPLICING OF ADENOVIRUS TYPE-5 E4-TRANSCRIPTS AND REGULATED CYTOPLASMIC ACCUMULATION OF E4 MESSENGER-RNA [J].
DIX, I ;
LEPPARD, KN .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3226-3231
[7]   Nuclear export of the E1B 55-kDa and E4 34-kDa adenoviral oncoproteins mediated by a rev-like signal sequence [J].
Dobbelstein, M ;
Roth, J ;
Kimberly, WT ;
Levine, AJ ;
Shenk, T .
EMBO JOURNAL, 1997, 16 (14) :4276-4284
[8]   Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor [J].
Dobner, T ;
Horikoshi, N ;
Rubenwolf, S ;
Shenk, T .
SCIENCE, 1996, 272 (5267) :1470-1473
[9]   The adenovirus type 5 E1B-55K oncoprotein actively shuttles in virus-infected cells, whereas transport of E4orf6 is mediated by a CRM1-Independent mechanism [J].
Dosch, T ;
Horn, F ;
Schneider, G ;
Krätzer, F ;
Dobner, T ;
Hauber, J ;
Stauber, RH .
JOURNAL OF VIROLOGY, 2001, 75 (12) :5677-5683
[10]   Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure [J].
Doucas, V ;
Ishov, AM ;
Romo, A ;
Juguilon, H ;
Weitzman, MD ;
Evans, RM ;
Maul, GG .
GENES & DEVELOPMENT, 1996, 10 (02) :196-207